Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population.
about
Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levelsTrough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis.In vitro study of the variable effects of proton pump inhibitors on voriconazoleTherapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole.Effect of cytochrome P450 2C19 polymorphisms on the clinical outcomes of voriconazole: a systematic review and meta-analysis.PharmGKB summary: voriconazole pathway, pharmacokinetics.Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study.Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study.Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy.Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.Prevalence of CYP2C19 Genetic Polymorphism among Normal People and Patients with Hepatic Diseases.
P2860
Q30491969-2634202F-FAE2-40F7-9853-8EA59F969535Q34532546-75E4B80D-774B-42FC-BA39-D2D95D391719Q35169112-E4EA2C24-0B2F-48F1-86A6-42EA912BCFBAQ35954530-DD9C71C9-06B4-44B9-B714-CF80A65336BBQ35960842-2E611DF5-7379-4395-98FD-251B77A5155AQ36608562-5BEE11BF-1EC6-4FB0-BBE5-35AFFBE8B6D6Q38889189-77B8EC85-2136-4A87-AB15-128EC27D4E88Q38918175-2140E814-1461-44EE-86DF-90E4C17D176AQ40562624-E866FEB5-2AC9-4657-997D-7A9EAA81FD2FQ41284722-63A2661A-CDCF-491E-A153-4EE5D6FE9DE6Q42101900-3027DC1A-7410-4659-A4BA-FB4827BF3BADQ47664190-02C18D77-AB34-449D-9A41-98670C6C7AC6Q52728829-AAA3986A-EDDE-43E7-B7F8-BA4DD4D2DFF5Q54257248-7ED0EC78-C73A-4325-8084-3B6EF7E0E707
P2860
Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clinical Impact of Cytochrome ...... nazole in a Korean Population.
@ast
Clinical Impact of Cytochrome ...... nazole in a Korean Population.
@en
type
label
Clinical Impact of Cytochrome ...... nazole in a Korean Population.
@ast
Clinical Impact of Cytochrome ...... nazole in a Korean Population.
@en
prefLabel
Clinical Impact of Cytochrome ...... nazole in a Korean Population.
@ast
Clinical Impact of Cytochrome ...... nazole in a Korean Population.
@en
P2093
P2860
P356
P1476
Clinical Impact of Cytochrome ...... onazole in a Korean Population
@en
P2093
Chulmin Park
Dong-Gun Lee
Eun-Young Kwon
Hyo-Jin Lee
Jae-Cheol Kwon
Jin-Hong Yoo
Jung-Hyun Choi
Su-Mi Choi
Sun Hee Park
P2860
P304
P356
10.3947/IC.2013.45.4.406
P577
2013-12-27T00:00:00Z